
Sign up to save your podcasts
Or
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST.
CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
4.9
149149 ratings
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST.
CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
1,864 Listeners
494 Listeners
3,320 Listeners
1,081 Listeners
186 Listeners
514 Listeners
320 Listeners
243 Listeners
414 Listeners
248 Listeners
363 Listeners
170 Listeners
25 Listeners
78 Listeners
216 Listeners